Atrial Fibrillation is associated with a 5-fold increased risk of stroke and thus stroke prevention is the fundamental part of management of Atrial Fibrillation (AF) patients. The choice of antithrombotic therapy for AF patients need to balance the risk of stroke against major bleeding.
Compared with non-Asians, the incidence of AF-related risks of stroke and bleeding in Asians is generally higher. By attending this webinar, you will have better knowledge and competence on:
- The current situation and challenges of stroke prevention in Atrial Fibrillation in Asia Pacific region
- The introduction of GDF-15 the strongest bleeding marker
- The clinical utility and validation data of the novel ABC (Age, Biomarker, Clinical History) risk scores in stroke prevention as well as it’s performance
